Changes in molecular forms of rat hepatic glutathione S-transferase during chemical hepatocarcinogenesis. 1984

A Kitahara, and K Satoh, and K Nishimura, and T Ishikawa, and K Ruike, and K Sato, and H Tsuda, and N Ito

Changes in molecular forms of hepatic cytosolic glutathione S-transferases (GST) during rat chemical hepatocarcinogenesis were investigated. GST activities toward 1-chloro-2,4-dinitrobenzene and 1,2-dichloro-4-nitrobenzene increased with the increased area of gamma-glutamyltranspeptidase-positive foci and hyperplastic nodules induced by diethylnitrosamine followed by 2-acetylaminofluorene plus hepatectomy. Among GSTs with high activities toward 1,2-dichloro-4-nitrobenzene, which were separated by carboxymethyl Sephadex column chromatography, the activity of GST-A ( YbYb ) markedly increased with increased activity towards 1,2-dichloro-4-nitrobenzene in livers bearing foci and nodules and in isolated nodules and hepatomas, while activities of GST-C ( YbYb ') and -D (Yb'Yb') changed little. It was demonstrated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and two-dimensional gel electrophoresis that Yb as well as Ya , a subunit of ligandin ( YaYa ) and GST-B ( YaYc ), increased in livers bearing foci and nodules, while Yc as well as Yb' changed little. A new placental GST form (GST-P), which has a subunit molecular weight of 21,500 or 26,000, according to the marker proteins used, and neutral pls of 6.8 and 6.3, is immunologically different from any form of basic GSTs and is very low in normal liver; also, it was markedly induced in livers bearing foci and nodules and in well-differentiated hepatomas but not by short-term administration of drugs such as 2-acetylaminofluorene, in contrast to GST-A and ligandin. These results indicate that GST-A and more especially GST-P could be new preneoplastic marker enzymes for chemical hepatocarcinogenesis.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D004052 Diethylnitrosamine A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. Nitrosodiethylamine,N-Nitrosodiethylamine,N Nitrosodiethylamine
D005260 Female Females
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal

Related Publications

A Kitahara, and K Satoh, and K Nishimura, and T Ishikawa, and K Ruike, and K Sato, and H Tsuda, and N Ito
September 1994, Carcinogenesis,
A Kitahara, and K Satoh, and K Nishimura, and T Ishikawa, and K Ruike, and K Sato, and H Tsuda, and N Ito
March 1993, Proceedings of the National Academy of Sciences of the United States of America,
A Kitahara, and K Satoh, and K Nishimura, and T Ishikawa, and K Ruike, and K Sato, and H Tsuda, and N Ito
March 1993, Carcinogenesis,
A Kitahara, and K Satoh, and K Nishimura, and T Ishikawa, and K Ruike, and K Sato, and H Tsuda, and N Ito
June 2004, The Biochemical journal,
A Kitahara, and K Satoh, and K Nishimura, and T Ishikawa, and K Ruike, and K Sato, and H Tsuda, and N Ito
October 1983, Gan,
A Kitahara, and K Satoh, and K Nishimura, and T Ishikawa, and K Ruike, and K Sato, and H Tsuda, and N Ito
June 2004, Cancer letters,
A Kitahara, and K Satoh, and K Nishimura, and T Ishikawa, and K Ruike, and K Sato, and H Tsuda, and N Ito
July 1986, Chemical & pharmaceutical bulletin,
A Kitahara, and K Satoh, and K Nishimura, and T Ishikawa, and K Ruike, and K Sato, and H Tsuda, and N Ito
June 1993, Toxicology letters,
A Kitahara, and K Satoh, and K Nishimura, and T Ishikawa, and K Ruike, and K Sato, and H Tsuda, and N Ito
April 1984, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
A Kitahara, and K Satoh, and K Nishimura, and T Ishikawa, and K Ruike, and K Sato, and H Tsuda, and N Ito
January 1991, Advances in enzyme regulation,
Copied contents to your clipboard!